Adverse Drug Reaction Classification System

ADR Ontology
ADR Term B-cell lymphoma
ADR ID BADD_A00407
ADR Hierarchy
01      Blood and lymphatic system disorders
01.15      Lymphomas non-Hodgkin's B-cell
01.15.01      B-cell lymphomas NEC
01.15.01.001      B-cell lymphoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.28      Lymphomas non-Hodgkin's B-cell
16.28.01      B-cell lymphomas NEC
16.28.01.001      B-cell lymphoma
Description A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. [MeSH]
MedDRA Code 10003899
MeSH ID D016393; D008224; D016393
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
B-cell lymphoma | B-cell lymphoma NOS | Nodular (follicular) lymphoma | Nodular lymphoma | Follicular B-cell non-Hodgkin's lymphoma | Lymphoma, B-Cell | Lymphoma, B Cell | B-Cell Lymphoma | B Cell Lymphoma | B-Cell Lymphomas | Lymphomas, B-Cell
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00047Afatinib0.000139%
BADD_D00195Azathioprine0.002060%
BADD_D00230Bendamustine0.000139%
BADD_D00356Carbamazepine0.000329%
BADD_D00479Cladribine0.000190%
BADD_D00511Clozapine0.010966%
BADD_D00551Cyclosporine0.000135%
BADD_D00586Darunavir--
BADD_D00628Dexlansoprazole--
BADD_D00680Dimethyl fumarate0.000478%
BADD_D00775Enzalutamide0.001471%
BADD_D00899Fingolimod hydrochloride--
BADD_D01008Gefitinib0.000139%
BADD_D01130Idelalisib0.000695%
BADD_D01136Imatinib0.000208%
BADD_D01253Lenalidomide0.007703%
BADD_D01392Mercaptopurine0.002510%
BADD_D01401Metformin0.000010%
BADD_D01418Methotrexate0.000803%
BADD_D01507Mycophenolate mofetil0.000341%
BADD_D01567Nilotinib0.000208%
BADD_D01858Propagermanium--
BADD_D01933Ribavirin0.004730%
BADD_D01954Rivaroxaban--
BADD_D02053Sofosbuvir0.000943%
BADD_D02105Tacrolimus0.001111%
BADD_D02165Teriflunomide0.000906%
BADD_D02192Thalidomide0.000302%
BADD_D02236Tofacitinib0.000755%
BADD_D02342Vedolizumab--
The 1th Page    1 2    Next   Last    Total 2 Pages